KLRG1 restricts memory T cell antitumor immunity

Lei Li; Shanshan Wan; Kaixiong Tao; Guobin Wang; Ende Zhao

doi:10.18632/oncotarget.11430

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

KLRG1 restricts memory T cell antitumor immunity

Lei Li, Shanshan Wan, Kaixiong Tao, Guobin Wang _ and Ende Zhao

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:61670-61678. https://doi.org/10.18632/oncotarget.11430

Metrics: PDF 3024 views | HTML 5300 views | ?

Abstract

Lei Li1, Shanshan Wan2, Kaixiong Tao1, Guobin Wang1, Ende Zhao1

1Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

2Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA

Correspondence to:

Guobin Wang, email: [email protected]

Ende Zhao, email: [email protected]

Keywords: KLRG1, senescence, memory T cells, antitumor immunity

Received: April 14, 2016 Accepted: August 13, 2016 Published: August 20, 2016

ABSTRACT

Killer cell lectin-like receptor subfamily G member 1 (KLRG1) has been found on human memory T lymphocytes. However, the roles of KLRG1 on human T cells especially in tumor microenvironment have not been fully understood. Our results showed KLRG1 expression on T cells significantly increased in tumor microenvironment. KLRG1⁺ T cells exhibited poor proliferative capacity with decreased effector cytokine production. Meanwhile, KLRG1⁺ T cells expressed abundant pro-inflammatory cytokines and demonstrated high level of Foxp3 expression. KLRG1⁺ T cells showed decreased expression of miRNA-101 and higher expression of CtBP2. Our results indicated KLRG1 might contribute to the impaired antitumor immunity of memory T cells in tumor microenvironment. Thus, repressing KLRG1 on human memory T cells might be a novel therapeutics against cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11430

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

KLRG1 restricts memory T cell antitumor immunity

Abstract